The popularity of Sildenafil initially drove a boom for major pharmaceutical companies, however recent developments present a complicated picture for those considering a stake. Generic competitors are eating into https://shaniazfbe559104.sharebyblog.com/41062893/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-investment